Trials / Completed
CompletedNCT03265509
Effect of Glutamine on Urinary Incontinence
Assessment of the Effect of Glutamine Supplementation in Addition to Exercise on Pelvic Floor Muscle Strength and Clinical Parameters in Women With Urinary Incontinence or Pelvic Organ Prolapse
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Istanbul University · Academic / Other
- Sex
- Female
- Age
- 45 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine to effect of additional oral glutamine to Kegel exercises on pelvic floor strength and clinical parameters of urinary incontinence in females with either urinary incontinence (stress and/or urgency) and pelvic prolapse.
Detailed description
Urinary incontinence is a prevalent and costly condition that affects approximately 38% of older community-dwelling women (age\>60 years). Incontinence predisposes patients to other health problems, contributes to depression and social isolation, is a significant source of dependency among the elderly, and is widely cited as a factor in nursing home admissions. Sarcopenia is age-related and is characterized by loss of muscle mass, strength and endurance. There is not only a decrease in the number of muscle fibers, but also atrophy in the remaining ones. Several studies indicate glutamine supplementations lead to better muscle performance by stimulate muscle producing in extremities. Similarly, we assume glutamine supplementation could increase pelvic muscle mass and improve the pelvic floor strength. From this point, using glutamine supplementation may effect positively on stress, urge or mixed incontinence, and pelvic prolapse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | glutamine supplementation | 30 g/day glutamine supplementation for three months |
| DIETARY_SUPPLEMENT | fantomalt supplementation | 30 g/day fantomalt supplementation for three months |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-09-01
- Completion
- 2018-09-01
- First posted
- 2017-08-29
- Last updated
- 2019-08-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03265509. Inclusion in this directory is not an endorsement.